Vrouwe, J. P. M., Kamerling, I. M. C., vanEsdonk, M. J., Metselaar, J. M., Stuurman, F. E., derPluijm, G. v., . . . Osanto, S. (2021). An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer. Wiley.
Cita Chicago Style (17a ed.)Vrouwe, Josephina P. M., Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, Jacobus Burggraaf, y Susanne Osanto. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.
Cita MLA (8a ed.)Vrouwe, Josephina P. M., et al. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.